Monday, December 14, 2020
Moderna doses adolescents in COVID-19 vaccine study, setting it up to target 2021-22 school year | FierceBiotech
Moderna doses adolescents in COVID-19 vaccine study, setting it up to target 2021-22 school year | FierceBiotech: Moderna has dosed the first adolescents in a phase 2/3 clinical trial designed to position its COVID-19 vaccine for use in children as young as 12 years old before the start of the 2021-22 school year.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment